2020
Public Health and Clinical Implications of Nutrition-Infection Interactions
Vermund S, Scott M, Humphries D. Public Health and Clinical Implications of Nutrition-Infection Interactions. Nutrition And Health 2020, 459-481. DOI: 10.1007/978-3-030-56913-6_16.Peer-Reviewed Original ResearchInfectious agentsNutritional statusClinical implicationsRole of obesityDefinitive risk factorsSeverity of malariaSuboptimal nutritional statusMajor infectious agentsHealth of personsClinical courseClinical managementRisk factorsClinical nutritionHigh mortalityInfectious diseasesCOVID-19ObesityPublic healthInfectionDiseaseSeverityNutritionHealthBacterial diseasesStatus
1998
The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants
Rogers A, Futterman D, Moscicki A, Wilson C, Ellenberg J, Vermund S. The REACH Project of the Adolescent Medicine HIV/AIDS Research Network: Design, Methods, and Selected Characteristics of Participants. Journal Of Adolescent Health 1998, 22: 300-311. PMID: 9561462, DOI: 10.1016/s1054-139x(97)00279-6.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAdolescentAdolescent Health ServicesCohort StudiesComorbidityData CollectionDisease ProgressionFemaleHealth Planning OrganizationsHIV InfectionsHumansMaleMulticenter Studies as TopicProgram DevelopmentProspective StudiesResearchResearch DesignUnited StatesConceptsAdolescent Medicine HIV/AIDS Research NetworkMedical chart abstractionGroup of HIVHIV-negative controlsAIDS Research NetworkHIV-positive youthLocal institutional review boardInstitutional review boardResearch NetworkREACH projectChart abstractionClinical characteristicsImmunologic profileClinical courseHIV pathogenesisPhysical examinationHIV epidemicStudy populationAdolescent careDisease comorbiditiesClinical experienceMultidisciplinary teamHormonal variationsStudy aimReview boardAnalysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines
Graham B, McElrath M, Connor R, Schwartz D, Gorse G, Keefer M, Mulligan M, Matthews T, Wolinsky S, Montefiori D, Vermund S, Lambert J, Corey L, Belshe R, Dolin R, Wright P, Korber B, Wolff M, Fast P, Group A. Analysis of Intercurrent Human Immunodeficiency Virus Type 1 Infections in Phase I and II Trials of Candidate AIDS Vaccines. The Journal Of Infectious Diseases 1998, 177: 310-309. PMID: 9466516, DOI: 10.1086/514209.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS VaccinesAmino Acid SequenceCD4 Lymphocyte CountFemaleHIV AntibodiesHIV Envelope Protein gp120HIV InfectionsHIV-1HumansImmunity, ActiveIncidenceMaleMiddle AgedMolecular Sequence DataNeutralization TestsPeptide FragmentsRisk-TakingSequence AnalysisSubstance Abuse, IntravenousViral LoadConceptsHIV-1 infectionHuman immunodeficiency virus type 1 (HIV-1) infectionVirus type 1 infectionCandidate AIDS vaccinesType 1 infectionAIDS vaccinePhase IHigh-risk sexual exposureVaccine-induced immune responsesComplete immunization scheduleEarly clinical courseCD4 lymphocyte countIntravenous drug useV3 loop amino acid sequencesUninfected subjectsVaccine recipientsLymphocyte countClinical courseImmunization scheduleSexual exposureVirus loadImmune responseControl groupDrug useInfection
1992
CD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review
Stein D, Korvick J, Vermund S. CD4+ Lymphocyte Cell Enumeration for Prediction of Clinical Course of Human Immunodeficiency Virus Disease: A Review. The Journal Of Infectious Diseases 1992, 165: 352-363. PMID: 1346152, DOI: 10.1093/infdis/165.2.352.Peer-Reviewed Original ResearchConceptsCell countHuman immunodeficiency virus (HIV) diseaseHuman immunodeficiency virus (HIV) infectionIntercurrent viral infectionPractical clinical perspectiveProgressive infectious processImmunodeficiency virus infectionImportant therapeutic decisionsAIDS CommentaryInfluence of drugsT helperClinical courseHIV infectionSurrogate markerTherapeutic decisionsVirus infectionInfectious processViral infectionCD4Clinical perspectiveEnd stageInfectionNational InstituteVirus diseaseCount
1990
How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus?
Vermund S, Hoth D. How can epidemiology assist in guiding interventions for the acquired immunodeficiency syndrome/human immunodeficiency virus? Annals Of Epidemiology 1990, 1: 141-155. PMID: 1669495, DOI: 10.1016/1047-2797(90)90005-d.Peer-Reviewed Original ResearchConceptsNew therapiesHIV infectionTherapeutic trialsClinical trialsImmunodeficiency syndrome/human immunodeficiency virusVaccine developmentHuman immunodeficiency virus (HIV) infectionRecent drug trialsImmunodeficiency virus infectionDevelopment of AIDSHost immunologic responseHuman immunodeficiency virusSuch clinical parametersFuture epidemiologic researchClinical therapeutic researchNatural history studiesUse of condomsEffect of treatmentClinical research methodsVariety of treatmentsAIDS/HIV epidemicClinical courseClinical outcomesClinical parametersImmunodeficiency virus